Kazufumi Ohmura
Overview
Explore the profile of Kazufumi Ohmura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohmura K, Tomita H, Okada H, Nakayama N, Ohe N, Izumo T, et al.
Brain Tumor Pathol
. 2025 Mar;
PMID: 40035915
Gliomas are the most common primary brain tumors in adults. However, glioblastoma is especially difficult to treat despite advancements in treatment. Therefore, new and more effective treatments are needed. The...
2.
Owashi E, Ohmura K, Shoda K, Yamada T, Kano K, Nakayama N, et al.
Acta Neurochir (Wien)
. 2024 May;
166(1):213.
PMID: 38740614
Background: Microvascular decompression (MVD), the standard surgical approach for hemifacial spasm (HFS), can be divided into the interposition and transposition methods. Although the risk of HFS recurrence following interposition has...
3.
Endothelial Glycocalyx in the Peripheral Capillaries is Injured Under Oxaliplatin-Induced Neuropathy
Kuroda T, Suzuki A, Okada H, Shimizu M, Watanabe D, Suzuki K, et al.
J Pain
. 2024 Jan;
25(6):104462.
PMID: 38211844
Oxaliplatin, a platinum-based anticancer drug, is associated with peripheral neuropathy (oxaliplatin-induced peripheral neuropathy, OIPN), which can lead to worsening of quality of life and treatment interruption. The endothelial glycocalyx, a...
4.
Ohmura K, Kinoshita T, Tomita H, Okada H, Shimizu M, Mori K, et al.
Biochem Biophys Res Commun
. 2023 Nov;
691:149286.
PMID: 38016339
Vincristine-induced peripheral neuropathy (VIPN) adversely affects the quality of life and treatment continuity of patients. The endothelial glycocalyx (eGCX) protects nerves from harmful substances released from the capillary vessels, but...
5.
Ohmura K, Tomita H, Hara A
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893105
Treating malignant glioma is challenging owing to its highly invasive potential in healthy brain tissue and the formation of intense surrounding edema. Peritumoral edema in gliomas can lead to severe...
6.
Resection of positive tissue on methionine-PET is associated with improved survival in glioblastomas
Ohmura K, Daimon T, Ikegame Y, Yano H, Yokoyama K, Kumagai M, et al.
Brain Behav
. 2023 Oct;
13(12):e3291.
PMID: 37846176
Background And Purpose: The volume of excised tumor in contrast-enhanced areas evaluated via magnetic resonance imaging is known to have a strong influence on the survival of patients with glioblastoma...
7.
Methionine-PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans
Ohmura K, Ikegame Y, Yano H, Shinoda J, Iwama T
J Neuroimaging
. 2023 May;
33(5):837-844.
PMID: 37246342
Background And Purpose: C-Methionine (MET)-PET is a useful tool in neuro-oncology. This study aimed to examine whether a combination of diagnostic variables associated with MET uptake could help distinguish between...
8.
Ohmura K, Kumagai N, Kumagai M, Ikegame Y, Shinoda J, Yano H, et al.
J Neuroimaging
. 2023 May;
33(4):652-660.
PMID: 37158779
Background And Purpose: C-methionine (MET)-PET is a useful tool in neuro-oncology. The T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign on MRI is a characteristic finding in lower grade gliomas with isocitrate...
9.
Yano H, Miwa K, Nakayama N, Maruyama T, Ohe N, Ikuta S, et al.
World Neurosurg X
. 2023 May;
19:100193.
PMID: 37123626
Objective: This study aimed to establish a method for differentiating between grades II and III astrocytomas using preoperative imaging. Methods: We retrospectively analyzed astrocytic tumors, including 18 grade II astrocytomas...